USPH - NYSE
U.S. Physical Therapy, Inc.
$61.87
-1.0%U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
At a Glance
Live SnapshotU.S. Physical Therapy, Inc. Management Team
Mr. Christopher J. Reading
Chief Executive Officer & Chairman
Compensation
$1,748,236
Mr. Carey P. Hendrickson
Chief Financial Officer
Compensation
$872,795
Mr. Graham D. Reeve M.B.A., P.T.
Chief Operating Officer - West
Compensation
$1,090,295
Mr. Richard S. Binstein
Executive Vice President, General Counsel & Secretary
Compensation
$738,603
Mr. Eric Joseph Williams
President & Chief Operating Officer
Compensation
$1,130,333
Ms. Jayne Fleck Pool ATC, PT, SCS
Senior Vice President & Chief Compliance Officer
Mr. Jake Martinez
Senior Vice President of Finance & Accounting
Mr. Chadd Pence
Senior Vice President of Information Systems
Mr. Jason Anderson
Vice President of Human Resources
U.S. Physical Therapy, Inc. Insider Positioning
During the last 12 months, insiders have purchased $276K and sold $1.28M worth of USPH shares, resulting in $1.00M of net selling activity.
3 Months
0
0.00
5.5K
445.83K
-446K
-$446K
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
4.0K
276.00K
1.3K
101.78K
+174K
+$174K
9-12 Months
0
0.00
8.7K
733.16K
-733K
-$733K
Top Buyers
Gilmartin Kathleen A
Director
$276K
Top Sellers
Reeve Graham D.
Officer: Coo
$474K
Binstein Richard
Officer: Evp Gen'L Counsel & Secretary
$415K
Reading Christopher J
Director, Officer: Chairman Of The Board And Ceo
$167K
Williams Eric Joseph
Officer: President And Coo
$85K
Ham Nancy
Director
$80K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $1.00M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Weak buy/sell ratio. Selling significantly exceeds buying—monitor for potential fundamental concerns.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SEC Filings
USPH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 16, 2026 | May 19, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 11, 2025 | May 20, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 15, 2024 | May 21, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 10, 2023 | April 10, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 04, 2022 | May 17, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 05, 2021 | May 18, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | June 26, 2020 | August 18, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 05, 2019 | May 21, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 05, 2018 | May 22, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | August 15, 2017 | October 03, 2017 | 2017 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.